Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Comparison of Blood Pressure Lowering Effect Between Fimasartan and Losartan [Phase 4]
Phase 4 trial updating a comparison of the blood pressure lowering effects of fimasartan versus losartan.
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Guideline Adherence for Heart Health [Phase 2]
Phase 2 trial update evaluating adherence to guidelines for heart health in people with cardiovascular diseases and related risk factors.
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Trial of Nonpharmacologic Interventions in Elderly (TONE) [Phase 3]
Clinical Trial Update: The Trial of Nonpharmacologic Interventions in Elderly (TONE) Phase 3 study has completed, evaluating nonpharmacologi…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Dietary Approaches to Stop Hypertension (DASH) [Phase 3]
The Phase 3 DASH dietary approach trial has completed, evaluating the impact of the DASH diet on hypertension and cardiovascular health.
-
FDA approval · 2016-11-04FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Aliskiren Hemifumarate from Prasco Laboratories.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Corever in the Treatment of Hypertension [Phase 3]
Phase 3 clinical trial update for Corever in hypertension, with the trial status listed as completed.
-
CLINICAL_TRIALS trial_result · 2016-11-04Clinical Trial Update: Latinos Understanding the Need for Adherence [NA]
A clinical trial update from San Diego State University indicates the study on adherence among Latino participants with cardiovascular risk …
-
FDA approval · 2016-11-03FDA Approved: OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a generic fixed-dose combination tablet of olmesartan medoxomil, amlodipine, and hydrochlorothiazide under an Original Applicat…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Tamoxifen Study [Phase 3]
This document reports the completion of a Phase 3 clinical trial evaluating tamoxifen.
-
FDA approval · 2016-11-01FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Tribenzor (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide) by Cosette Phar…
-
FDA approval · 2016-11-01FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for BENICAR (olmesartan medoxomil) filed by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2016-11-01FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) from Cosette Pharmaceuticals, Inc., appr…
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of HCP1302 [Phase 3]
This is a Phase 3 clinical trial update on HCP1302 evaluating its efficacy and safety in erectile dysfunction and hypertension, with the tri…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Renal Sympathetic Denervation in Mild Refractory Hypertension [Phase 4]
A Phase 4 clinical trial of renal sympathetic denervation for mild refractory hypertension has completed.
-
FDA approval · 2016-10-28FDA Approved: AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original ANDA for a generic combination of amlodipine besylate and olmesartan medoxomil for hypertensi…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Virtual Hypertension Clinic [NA]
A clinical trial evaluating a Virtual Hypertension Clinic has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Sympathetic and Blood Pressure Responses to Aerobic Exercise and Guided Respiration in Hypertensives [NA]
This completed clinical trial studied how aerobic exercise and guided respiration influence sympathetic activity and blood pressure in adult…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Young Adult Hypertension Feasibility Study [NA]
A feasibility study exploring hypertension management in young adults has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Multi-electrode Radiofrequency Renal Denervation System Feasibility Study [NA]
This update reports the completion of a feasibility study for Medtronic Vascular's multi-electrode renal denervation system intended to trea…
-
FDA approval · 2016-10-26FDA Approved: OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE — Original Application (Par Health USA, LLC)
The FDA approved a generic fixed-dose combination tablet containing olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide for h…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Effects of Purple Vegetables on Cardiovascular Disease (CVD) Risk Factors [Phase 1]
Phase 1 clinical trial exploring the effects of purple vegetables on cardiovascular disease risk factors, including hypertension and hyperch…
-
FDA approval · 2016-10-26FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's combination product amlodipine and olmesartan medoxomil as an original application, providin…
-
CLINICAL_TRIALS research · 2016-10-25Clinical Trial Update: The Effects of Aronia Juice Polyphenols on Cardiovascular Disease Risk [NA]
This entry reports a clinical trial sponsored by the University of Belgrade examining whether polyphenols from aronia juice influence cardio…
-
FDA approval · 2016-10-24FDA Approved: EDARBYCLOR — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for EDARBYCLOR (azilsartan medoxomil and chlorthalidone) filed by Azurity Pharmaceuticals, appro…
-
FDA approval · 2016-10-24FDA Approved: EDARBI — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for EDARBI (AZILSARTAN KAMEDOXOMIL) from Azurity Pharmaceuticals, Inc.